Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Intravascular Temperature Management Market

ID: MRFR/HC/30931-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Intravascular Temperature Management Market Research Report By Type (Conventional Intravascular Temperature Management Devices, Advanced Intravascular Temperature Management Devices, Accessories and Consumables), By Application (Cardiac Surgery, Neurovascular Surgery, Trauma Surgery, Post-operative Care), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Method (Intravenous Cooling, Intravenous Heating) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Intravascular Temperature Management Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Billion)
  49.     4.1.1 Conventional Intravascular Temperature Management Devices
  50.     4.1.2 Advanced Intravascular Temperature Management Devices
  51.     4.1.3 Accessories and Consumables
  52.   4.2 Healthcare, BY Application (USD Billion)
  53.     4.2.1 Cardiac Surgery
  54.     4.2.2 Neurovascular Surgery
  55.     4.2.3 Trauma Surgery
  56.     4.2.4 Post-operative Care
  57.   4.3 Healthcare, BY End User (USD Billion)
  58.     4.3.1 Hospitals
  59.     4.3.2 Ambulatory Surgical Centers
  60.     4.3.3 Specialty Clinics
  61.   4.4 Healthcare, BY Method (USD Billion)
  62.     4.4.1 Intravenous Cooling
  63.     4.4.2 Intravenous Heating
  64.   4.5 Healthcare, BY Region (USD Billion)
  65.     4.5.1 North America
  66.       4.5.1.1 US
  67.       4.5.1.2 Canada
  68.     4.5.2 Europe
  69.       4.5.2.1 Germany
  70.       4.5.2.2 UK
  71.       4.5.2.3 France
  72.       4.5.2.4 Russia
  73.       4.5.2.5 Italy
  74.       4.5.2.6 Spain
  75.       4.5.2.7 Rest of Europe
  76.     4.5.3 APAC
  77.       4.5.3.1 China
  78.       4.5.3.2 India
  79.       4.5.3.3 Japan
  80.       4.5.3.4 South Korea
  81.       4.5.3.5 Malaysia
  82.       4.5.3.6 Thailand
  83.       4.5.3.7 Indonesia
  84.       4.5.3.8 Rest of APAC
  85.     4.5.4 South America
  86.       4.5.4.1 Brazil
  87.       4.5.4.2 Mexico
  88.       4.5.4.3 Argentina
  89.       4.5.4.4 Rest of South America
  90.     4.5.5 MEA
  91.       4.5.5.1 GCC Countries
  92.       4.5.5.2 South Africa
  93.       4.5.5.3 Rest of MEA
  94. 5 SECTION V: COMPETITIVE ANALYSIS
  95.   5.1 Competitive Landscape
  96.     5.1.1 Overview
  97.     5.1.2 Competitive Analysis
  98.     5.1.3 Market share Analysis
  99.     5.1.4 Major Growth Strategy in the Healthcare
  100.     5.1.5 Competitive Benchmarking
  101.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  102.     5.1.7 Key developments and growth strategies
  103.       5.1.7.1 New Product Launch/Service Deployment
  104.       5.1.7.2 Merger & Acquisitions
  105.       5.1.7.3 Joint Ventures
  106.     5.1.8 Major Players Financial Matrix
  107.       5.1.8.1 Sales and Operating Income
  108.       5.1.8.2 Major Players R&D Expenditure. 2023
  109.   5.2 Company Profiles
  110.     5.2.1 Zoll Medical Corporation (US)
  111.       5.2.1.1 Financial Overview
  112.       5.2.1.2 Products Offered
  113.       5.2.1.3 Key Developments
  114.       5.2.1.4 SWOT Analysis
  115.       5.2.1.5 Key Strategies
  116.     5.2.2 Medtronic plc (IE)
  117.       5.2.2.1 Financial Overview
  118.       5.2.2.2 Products Offered
  119.       5.2.2.3 Key Developments
  120.       5.2.2.4 SWOT Analysis
  121.       5.2.2.5 Key Strategies
  122.     5.2.3 Bard Medical (US)
  123.       5.2.3.1 Financial Overview
  124.       5.2.3.2 Products Offered
  125.       5.2.3.3 Key Developments
  126.       5.2.3.4 SWOT Analysis
  127.       5.2.3.5 Key Strategies
  128.     5.2.4 Stryker Corporation (US)
  129.       5.2.4.1 Financial Overview
  130.       5.2.4.2 Products Offered
  131.       5.2.4.3 Key Developments
  132.       5.2.4.4 SWOT Analysis
  133.       5.2.4.5 Key Strategies
  134.     5.2.5 Smiths Medical (US)
  135.       5.2.5.1 Financial Overview
  136.       5.2.5.2 Products Offered
  137.       5.2.5.3 Key Developments
  138.       5.2.5.4 SWOT Analysis
  139.       5.2.5.5 Key Strategies
  140.     5.2.6 ThermoTek (US)
  141.       5.2.6.1 Financial Overview
  142.       5.2.6.2 Products Offered
  143.       5.2.6.3 Key Developments
  144.       5.2.6.4 SWOT Analysis
  145.       5.2.6.5 Key Strategies
  146.     5.2.7 3M Company (US)
  147.       5.2.7.1 Financial Overview
  148.       5.2.7.2 Products Offered
  149.       5.2.7.3 Key Developments
  150.       5.2.7.4 SWOT Analysis
  151.       5.2.7.5 Key Strategies
  152.     5.2.8 Baxter International Inc. (US)
  153.       5.2.8.1 Financial Overview
  154.       5.2.8.2 Products Offered
  155.       5.2.8.3 Key Developments
  156.       5.2.8.4 SWOT Analysis
  157.       5.2.8.5 Key Strategies
  158.   5.3 Appendix
  159.     5.3.1 References
  160.     5.3.2 Related Reports
  161. 6 LIST OF FIGURES
  162.   6.1 MARKET SYNOPSIS
  163.   6.2 NORTH AMERICA MARKET ANALYSIS
  164.   6.3 US MARKET ANALYSIS BY TYPE
  165.   6.4 US MARKET ANALYSIS BY APPLICATION
  166.   6.5 US MARKET ANALYSIS BY END USER
  167.   6.6 US MARKET ANALYSIS BY METHOD
  168.   6.7 CANADA MARKET ANALYSIS BY TYPE
  169.   6.8 CANADA MARKET ANALYSIS BY APPLICATION
  170.   6.9 CANADA MARKET ANALYSIS BY END USER
  171.   6.10 CANADA MARKET ANALYSIS BY METHOD
  172.   6.11 EUROPE MARKET ANALYSIS
  173.   6.12 GERMANY MARKET ANALYSIS BY TYPE
  174.   6.13 GERMANY MARKET ANALYSIS BY APPLICATION
  175.   6.14 GERMANY MARKET ANALYSIS BY END USER
  176.   6.15 GERMANY MARKET ANALYSIS BY METHOD
  177.   6.16 UK MARKET ANALYSIS BY TYPE
  178.   6.17 UK MARKET ANALYSIS BY APPLICATION
  179.   6.18 UK MARKET ANALYSIS BY END USER
  180.   6.19 UK MARKET ANALYSIS BY METHOD
  181.   6.20 FRANCE MARKET ANALYSIS BY TYPE
  182.   6.21 FRANCE MARKET ANALYSIS BY APPLICATION
  183.   6.22 FRANCE MARKET ANALYSIS BY END USER
  184.   6.23 FRANCE MARKET ANALYSIS BY METHOD
  185.   6.24 RUSSIA MARKET ANALYSIS BY TYPE
  186.   6.25 RUSSIA MARKET ANALYSIS BY APPLICATION
  187.   6.26 RUSSIA MARKET ANALYSIS BY END USER
  188.   6.27 RUSSIA MARKET ANALYSIS BY METHOD
  189.   6.28 ITALY MARKET ANALYSIS BY TYPE
  190.   6.29 ITALY MARKET ANALYSIS BY APPLICATION
  191.   6.30 ITALY MARKET ANALYSIS BY END USER
  192.   6.31 ITALY MARKET ANALYSIS BY METHOD
  193.   6.32 SPAIN MARKET ANALYSIS BY TYPE
  194.   6.33 SPAIN MARKET ANALYSIS BY APPLICATION
  195.   6.34 SPAIN MARKET ANALYSIS BY END USER
  196.   6.35 SPAIN MARKET ANALYSIS BY METHOD
  197.   6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE
  198.   6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  199.   6.38 REST OF EUROPE MARKET ANALYSIS BY END USER
  200.   6.39 REST OF EUROPE MARKET ANALYSIS BY METHOD
  201.   6.40 APAC MARKET ANALYSIS
  202.   6.41 CHINA MARKET ANALYSIS BY TYPE
  203.   6.42 CHINA MARKET ANALYSIS BY APPLICATION
  204.   6.43 CHINA MARKET ANALYSIS BY END USER
  205.   6.44 CHINA MARKET ANALYSIS BY METHOD
  206.   6.45 INDIA MARKET ANALYSIS BY TYPE
  207.   6.46 INDIA MARKET ANALYSIS BY APPLICATION
  208.   6.47 INDIA MARKET ANALYSIS BY END USER
  209.   6.48 INDIA MARKET ANALYSIS BY METHOD
  210.   6.49 JAPAN MARKET ANALYSIS BY TYPE
  211.   6.50 JAPAN MARKET ANALYSIS BY APPLICATION
  212.   6.51 JAPAN MARKET ANALYSIS BY END USER
  213.   6.52 JAPAN MARKET ANALYSIS BY METHOD
  214.   6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE
  215.   6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  216.   6.55 SOUTH KOREA MARKET ANALYSIS BY END USER
  217.   6.56 SOUTH KOREA MARKET ANALYSIS BY METHOD
  218.   6.57 MALAYSIA MARKET ANALYSIS BY TYPE
  219.   6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION
  220.   6.59 MALAYSIA MARKET ANALYSIS BY END USER
  221.   6.60 MALAYSIA MARKET ANALYSIS BY METHOD
  222.   6.61 THAILAND MARKET ANALYSIS BY TYPE
  223.   6.62 THAILAND MARKET ANALYSIS BY APPLICATION
  224.   6.63 THAILAND MARKET ANALYSIS BY END USER
  225.   6.64 THAILAND MARKET ANALYSIS BY METHOD
  226.   6.65 INDONESIA MARKET ANALYSIS BY TYPE
  227.   6.66 INDONESIA MARKET ANALYSIS BY APPLICATION
  228.   6.67 INDONESIA MARKET ANALYSIS BY END USER
  229.   6.68 INDONESIA MARKET ANALYSIS BY METHOD
  230.   6.69 REST OF APAC MARKET ANALYSIS BY TYPE
  231.   6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION
  232.   6.71 REST OF APAC MARKET ANALYSIS BY END USER
  233.   6.72 REST OF APAC MARKET ANALYSIS BY METHOD
  234.   6.73 SOUTH AMERICA MARKET ANALYSIS
  235.   6.74 BRAZIL MARKET ANALYSIS BY TYPE
  236.   6.75 BRAZIL MARKET ANALYSIS BY APPLICATION
  237.   6.76 BRAZIL MARKET ANALYSIS BY END USER
  238.   6.77 BRAZIL MARKET ANALYSIS BY METHOD
  239.   6.78 MEXICO MARKET ANALYSIS BY TYPE
  240.   6.79 MEXICO MARKET ANALYSIS BY APPLICATION
  241.   6.80 MEXICO MARKET ANALYSIS BY END USER
  242.   6.81 MEXICO MARKET ANALYSIS BY METHOD
  243.   6.82 ARGENTINA MARKET ANALYSIS BY TYPE
  244.   6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION
  245.   6.84 ARGENTINA MARKET ANALYSIS BY END USER
  246.   6.85 ARGENTINA MARKET ANALYSIS BY METHOD
  247.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
  248.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  249.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
  250.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY METHOD
  251.   6.90 MEA MARKET ANALYSIS
  252.   6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE
  253.   6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  254.   6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER
  255.   6.94 GCC COUNTRIES MARKET ANALYSIS BY METHOD
  256.   6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE
  257.   6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  258.   6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER
  259.   6.98 SOUTH AFRICA MARKET ANALYSIS BY METHOD
  260.   6.99 REST OF MEA MARKET ANALYSIS BY TYPE
  261.   6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION
  262.   6.101 REST OF MEA MARKET ANALYSIS BY END USER
  263.   6.102 REST OF MEA MARKET ANALYSIS BY METHOD
  264.   6.103 KEY BUYING CRITERIA OF HEALTHCARE
  265.   6.104 RESEARCH PROCESS OF MRFR
  266.   6.105 DRO ANALYSIS OF HEALTHCARE
  267.   6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  268.   6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  269.   6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
  270.   6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  271.   6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
  272.   6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  273.   6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  274.   6.113 HEALTHCARE, BY END USER, 2024 (% SHARE)
  275.   6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  276.   6.115 HEALTHCARE, BY METHOD, 2024 (% SHARE)
  277.   6.116 HEALTHCARE, BY METHOD, 2024 TO 2035 (USD Billion)
  278.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  279. 7 LIST OF TABLES
  280.   7.1 LIST OF ASSUMPTIONS
  281.     7.1.1
  282.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  283.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  284.     7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  285.     7.2.3 BY END USER, 2025-2035 (USD Billion)
  286.     7.2.4 BY METHOD, 2025-2035 (USD Billion)
  287.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  288.     7.3.1 BY TYPE, 2025-2035 (USD Billion)
  289.     7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  290.     7.3.3 BY END USER, 2025-2035 (USD Billion)
  291.     7.3.4 BY METHOD, 2025-2035 (USD Billion)
  292.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  293.     7.4.1 BY TYPE, 2025-2035 (USD Billion)
  294.     7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  295.     7.4.3 BY END USER, 2025-2035 (USD Billion)
  296.     7.4.4 BY METHOD, 2025-2035 (USD Billion)
  297.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  298.     7.5.1 BY TYPE, 2025-2035 (USD Billion)
  299.     7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  300.     7.5.3 BY END USER, 2025-2035 (USD Billion)
  301.     7.5.4 BY METHOD, 2025-2035 (USD Billion)
  302.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  303.     7.6.1 BY TYPE, 2025-2035 (USD Billion)
  304.     7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  305.     7.6.3 BY END USER, 2025-2035 (USD Billion)
  306.     7.6.4 BY METHOD, 2025-2035 (USD Billion)
  307.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  308.     7.7.1 BY TYPE, 2025-2035 (USD Billion)
  309.     7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  310.     7.7.3 BY END USER, 2025-2035 (USD Billion)
  311.     7.7.4 BY METHOD, 2025-2035 (USD Billion)
  312.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  313.     7.8.1 BY TYPE, 2025-2035 (USD Billion)
  314.     7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  315.     7.8.3 BY END USER, 2025-2035 (USD Billion)
  316.     7.8.4 BY METHOD, 2025-2035 (USD Billion)
  317.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  318.     7.9.1 BY TYPE, 2025-2035 (USD Billion)
  319.     7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  320.     7.9.3 BY END USER, 2025-2035 (USD Billion)
  321.     7.9.4 BY METHOD, 2025-2035 (USD Billion)
  322.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  323.     7.10.1 BY TYPE, 2025-2035 (USD Billion)
  324.     7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  325.     7.10.3 BY END USER, 2025-2035 (USD Billion)
  326.     7.10.4 BY METHOD, 2025-2035 (USD Billion)
  327.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  328.     7.11.1 BY TYPE, 2025-2035 (USD Billion)
  329.     7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  330.     7.11.3 BY END USER, 2025-2035 (USD Billion)
  331.     7.11.4 BY METHOD, 2025-2035 (USD Billion)
  332.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  333.     7.12.1 BY TYPE, 2025-2035 (USD Billion)
  334.     7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  335.     7.12.3 BY END USER, 2025-2035 (USD Billion)
  336.     7.12.4 BY METHOD, 2025-2035 (USD Billion)
  337.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  338.     7.13.1 BY TYPE, 2025-2035 (USD Billion)
  339.     7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  340.     7.13.3 BY END USER, 2025-2035 (USD Billion)
  341.     7.13.4 BY METHOD, 2025-2035 (USD Billion)
  342.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  343.     7.14.1 BY TYPE, 2025-2035 (USD Billion)
  344.     7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  345.     7.14.3 BY END USER, 2025-2035 (USD Billion)
  346.     7.14.4 BY METHOD, 2025-2035 (USD Billion)
  347.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  348.     7.15.1 BY TYPE, 2025-2035 (USD Billion)
  349.     7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  350.     7.15.3 BY END USER, 2025-2035 (USD Billion)
  351.     7.15.4 BY METHOD, 2025-2035 (USD Billion)
  352.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  353.     7.16.1 BY TYPE, 2025-2035 (USD Billion)
  354.     7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  355.     7.16.3 BY END USER, 2025-2035 (USD Billion)
  356.     7.16.4 BY METHOD, 2025-2035 (USD Billion)
  357.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  358.     7.17.1 BY TYPE, 2025-2035 (USD Billion)
  359.     7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  360.     7.17.3 BY END USER, 2025-2035 (USD Billion)
  361.     7.17.4 BY METHOD, 2025-2035 (USD Billion)
  362.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  363.     7.18.1 BY TYPE, 2025-2035 (USD Billion)
  364.     7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  365.     7.18.3 BY END USER, 2025-2035 (USD Billion)
  366.     7.18.4 BY METHOD, 2025-2035 (USD Billion)
  367.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  368.     7.19.1 BY TYPE, 2025-2035 (USD Billion)
  369.     7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  370.     7.19.3 BY END USER, 2025-2035 (USD Billion)
  371.     7.19.4 BY METHOD, 2025-2035 (USD Billion)
  372.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  373.     7.20.1 BY TYPE, 2025-2035 (USD Billion)
  374.     7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  375.     7.20.3 BY END USER, 2025-2035 (USD Billion)
  376.     7.20.4 BY METHOD, 2025-2035 (USD Billion)
  377.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  378.     7.21.1 BY TYPE, 2025-2035 (USD Billion)
  379.     7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  380.     7.21.3 BY END USER, 2025-2035 (USD Billion)
  381.     7.21.4 BY METHOD, 2025-2035 (USD Billion)
  382.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  383.     7.22.1 BY TYPE, 2025-2035 (USD Billion)
  384.     7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  385.     7.22.3 BY END USER, 2025-2035 (USD Billion)
  386.     7.22.4 BY METHOD, 2025-2035 (USD Billion)
  387.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  388.     7.23.1 BY TYPE, 2025-2035 (USD Billion)
  389.     7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  390.     7.23.3 BY END USER, 2025-2035 (USD Billion)
  391.     7.23.4 BY METHOD, 2025-2035 (USD Billion)
  392.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  393.     7.24.1 BY TYPE, 2025-2035 (USD Billion)
  394.     7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  395.     7.24.3 BY END USER, 2025-2035 (USD Billion)
  396.     7.24.4 BY METHOD, 2025-2035 (USD Billion)
  397.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  398.     7.25.1 BY TYPE, 2025-2035 (USD Billion)
  399.     7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  400.     7.25.3 BY END USER, 2025-2035 (USD Billion)
  401.     7.25.4 BY METHOD, 2025-2035 (USD Billion)
  402.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  403.     7.26.1 BY TYPE, 2025-2035 (USD Billion)
  404.     7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  405.     7.26.3 BY END USER, 2025-2035 (USD Billion)
  406.     7.26.4 BY METHOD, 2025-2035 (USD Billion)
  407.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  408.     7.27.1 BY TYPE, 2025-2035 (USD Billion)
  409.     7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  410.     7.27.3 BY END USER, 2025-2035 (USD Billion)
  411.     7.27.4 BY METHOD, 2025-2035 (USD Billion)
  412.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  413.     7.28.1 BY TYPE, 2025-2035 (USD Billion)
  414.     7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  415.     7.28.3 BY END USER, 2025-2035 (USD Billion)
  416.     7.28.4 BY METHOD, 2025-2035 (USD Billion)
  417.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  418.     7.29.1 BY TYPE, 2025-2035 (USD Billion)
  419.     7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  420.     7.29.3 BY END USER, 2025-2035 (USD Billion)
  421.     7.29.4 BY METHOD, 2025-2035 (USD Billion)
  422.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  423.     7.30.1 BY TYPE, 2025-2035 (USD Billion)
  424.     7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  425.     7.30.3 BY END USER, 2025-2035 (USD Billion)
  426.     7.30.4 BY METHOD, 2025-2035 (USD Billion)
  427.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  428.     7.31.1
  429.   7.32 ACQUISITION/PARTNERSHIP
  430.     7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Conventional Intravascular Temperature Management Devices
  • Advanced Intravascular Temperature Management Devices
  • Accessories and Consumables

Healthcare By Application (USD Billion, 2025-2035)

  • Cardiac Surgery
  • Neurovascular Surgery
  • Trauma Surgery
  • Post-operative Care

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Healthcare By Method (USD Billion, 2025-2035)

  • Intravenous Cooling
  • Intravenous Heating

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions